Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 145 clinical trials
Featured trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of INCB099280 in participants with select solid tumors

  • 0 views
  • 19 Jun, 2022
  • 16 locations
  • 38 views
  • 14 Feb, 2022
  • 1 location
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

cisplatin concurrent chemoradiotherapy alone in treating patients with locoregionally recurrent nasopharyngeal carcinoma.

  • 0 views
  • 26 Jul, 2021
  • 1 location
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

  • 0 views
  • 07 Oct, 2021
  • 1 location
Combining RT With Toripalimab and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

Incidences of de novo metastatic nasopharyngeal carcinoma range from 6% to 8% at the time of presentation. For the initial diagnosis of metastatic NPC, PD-1 plus chemotherapy yields a

  • 0 views
  • 07 Jun, 2022
  • 1 location
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (IRCNPC)

nasopharyngeal carcinoma (NPC) patients with a satisfactory tumor response (complete response or partial response) after neoadjuvant chemotherapy (NACT).

  • 0 views
  • 25 Feb, 2022
  • 1 location
  • 0 views
  • 01 Mar, 2022
  • 1 location
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

chemoradiotherapy alone in recurrent nasopharyngeal carcinoma patients.

  • 0 views
  • 25 Mar, 2022
  • 5 locations
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

To explore the effect of Camrelizumab and chemotherapy combining with endoscopic surgery in the treatment of recurrent nasopharyngeal carcinoma.

  • 0 views
  • 02 Sep, 2021
  • 7 locations
TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

of locally advanced nasopharyngeal carcinoma: the efficacy, toxicity and quality of life, and further improvement Survival rate and improve the quality of life.

  • 8 views
  • 04 Mar, 2022
  • 1 location